help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 52, No. 3 557-561
doi:10.1210/jcem-52-3-557
Copyright © 1981 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RABIN, D.
Right arrow Articles by MCNEIL, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RABIN, D.
Right arrow Articles by MCNEIL, L. W.

Long Term Therapy with Luteinizing Hormone-Releasing Hormone in Isolated Gonadotropin Deficiency: Failure of Therapeutic Response*

DAVID RABIN{dagger} and L. W. MCNEIL{ddagger}

Division of Endocrinology, Department of Medicine, Vanderbilt University School of Medicine Nashville, Tennessee 37232

We have evaluated the therapeutic response to exogenous LRH (1 mg, sc, either twice daily or three times daily) in six subjects with isolated gonadotropin deficiency. Four males were treated for 6 months, of whom two showed a transient rise in serum testosterone. However, testosterone levels subsequently remained at pretreatment levels in each of the four subjects during LRH therapy. One of the two female subjects displayed a transient rise in 17β-estradiol levels. All four males showed a notable rise in testosterone after hCG, and the one female tested responded to menotropins while receiving LRH. We propose that the number of quanta of gonadotropins released per day with our therapeutic regimen was inadequate to generate a normal gonadal response.

* This work was supported by the following grants in aid: USPHS HD-10128, NICHHD Contract N01-HD-9-2843, Clinical Research Center 5-M01 RR-95, Population Center HD-05797, and Training Grants T32-AM-07061 and T32-HD-07043.

{dagger} To whom requests for reprints should be addressed.

{ddagger} Present address: Department of Internal Medicine, Meharry Medical College, Nashville, Tennessee 37208.

Received June 16, 1980.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
D. I. SPRATT, J. S. FINKELSTEIN, L. ST.L. O'DEA, T. M. BADGER, P. N. RAO, J. D. CAMPBELL, and W. F. CROWLEY Jr.
Long-Term Administration of Gonadotropin-Releasing Hormone in Men with Idiopathic Hypogonadotropic Hypogonadism: A Model for Studies of the Hormone's Physiologic Effects
Ann Intern Med, December 1, 1986; 105(6): 848 - 855.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C. B. Hammond and S. J. Ory
Diagnostic and Therapeutic Uses of Gonadotropin-Releasing Hormone
Arch Intern Med, September 1, 1985; 145(9): 1690 - 1697.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society